A detailed history of Parian Global Management LP transactions in Adma Biologics, Inc. stock. As of the latest transaction made, Parian Global Management LP holds 50,000 shares of ADMA stock, worth $819,000. This represents 0.4% of its overall portfolio holdings.

Number of Shares
50,000
Holding current value
$819,000
% of portfolio
0.4%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2022

Nov 14, 2022

BUY
$2.03 - $2.86 $101,499 - $143,000
50,000 New
50,000 $122,000
Q2 2022

Aug 15, 2022

SELL
$1.43 - $2.2 $450,450 - $693,000
-315,000 Closed
0 $0
Q1 2022

May 16, 2022

BUY
$1.28 - $1.83 $403,200 - $576,450
315,000 New
315,000 $576,000

Others Institutions Holding ADMA

About ADMA BIOLOGICS, INC.


  • Ticker ADMA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 196,356,992
  • Market Cap $3.22B
  • Description
  • ADMA Biologics, Inc., a biopharmaceutical company, engages in developing, manufacturing, and marketing specialty plasma-derived biologics for the treatment of immune deficiencies and infectious diseases in the United States and internationally. It offers BIVIGAM, an intravenous immune globulin (IVIG) product indicated for the treatment of primar...
More about ADMA
Track This Portfolio

Track Parian Global Management LP Portfolio

Follow Parian Global Management LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Parian Global Management LP, based on Form 13F filings with the SEC.

News

Stay updated on Parian Global Management LP with notifications on news.